No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs593806 |
chr13:96740247-96740248 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs193290659 |
chr13:96740252-96740253 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs111584207 |
chr13:96740271-96740272 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs34934639 |
chr13:96740278-96740279 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs71434511 |
chr13:96740310-96740311 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs139808821 |
chr13:96740315-96740316 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs184999479 |
chr13:96740390-96740391 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs199624294 |
chr13:96740423-96740424 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs188756393 |
chr13:96740430-96740431 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs143710686 |
chr13:96740482-96740483 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs146807406 |
chr13:96740489-96740490 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs558695843 |
chr13:96740569-96740570 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs575365380 |
chr13:96740584-96740585 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs139522900 |
chr13:96740672-96740673 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192594040 |
chr13:96740719-96740720 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs183937607 |
chr13:96740732-96740733 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs374388259 |
chr13:96740737-96740738 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs576414190 |
chr13:96740817-96740818 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs367562618 |
chr13:96740819-96740820 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs560126881 |
chr13:96740898-96740899 |
Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs372104945 |
chr13:96740931-96740932 |
Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs576634535 |
chr13:96741102-96741103 |
Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs481049 |
chr13:96741182-96741183 |
Bivalent Enhancer Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs577470309 |
chr13:96741226-96741227 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs530877416 |
chr13:96741233-96741234 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs367959458 |
chr13:96741237-96741238 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs188664851 |
chr13:96741328-96741329 |
Weak transcription Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs550732379 |
chr13:96741341-96741342 |
Weak transcription Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs180829755 |
chr13:96741360-96741361 |
Weak transcription Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs34763066 |
chr13:96741365-96741366 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs530373161 |
chr13:96741395-96741396 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs547263882 |
chr13:96741408-96741409 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs59409680 |
chr13:96741415-96741416 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs75538526 |
chr13:96741468-96741469 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs144181915 |
chr13:96741469-96741470 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs145431571 |
chr13:96741513-96741514 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs183767516 |
chr13:96741554-96741555 |
Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs531284980 |
chr13:96741613-96741614 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs4547219 |
chr13:96741656-96741657 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs11616724 |
chr13:96741670-96741671 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs34481001 |
chr13:96741683-96741684 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs533511056 |
chr13:96741713-96741714 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs190225954 |
chr13:96741778-96741779 |
Bivalent/Poised TSS Flanking Active TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs182409868 |
chr13:96741804-96741805 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs576695840 |
chr13:96741852-96741853 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs11618108 |
chr13:96741862-96741863 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
47 |
rs149217724 |
chr13:96741912-96741913 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs186636052 |
chr13:96741940-96741941 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs191938059 |
chr13:96741941-96741942 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs143356746 |
chr13:96741951-96741952 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|